CareDx, Inc logo CDNA - CareDx, Inc

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 10
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $24.00 DETAILS
HIGH: $28.00
LOW: $18.00
MEDIAN: $26.00
CONSENSUS: $24.00
UPSIDE: 10.96%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue 379.8 333.8 280.3 321.8 296.4 192.2 127.1 76.6 48.3 40.6 28.1 27.3 22.1 20.5
Cost of Revenue 125.4 109.6 102.0 112.2 97.4 63.1 45.5 33.0 21.4 21.1 10.3 8.5 9.1 7.9
Gross Profit 254.4 224.2 178.3 209.6 199.0 129.1 81.6 43.6 27.0 19.5 17.9 18.8 13.0 12.5
Operating Expenses
R&D Expenses 71.4 72.4 81.9 90.4 76.5 48.9 30.7 14.5 12.4 12.4 9.3 3.8 3.2 4.8
SG&A Expenses 210.2 205.5 201.2 196.4 152.2 102.7 75.4 43.6 31.7 31.9 20.6 14.9 10.7 10.1
Other Expenses (6.2) (94.5) 98.6 0 0 0 0 (0.2) 0 0 (0.2) 0.1 0 (0.0)
Operating Expenses 275.4 183.4 381.7 286.8 228.7 151.6 106.1 58.1 44.1 44.3 29.9 18.8 13.9 14.9
Operating Income
Operating Income (21.0) 40.8 (203.4) (77.2) (29.7) (22.5) (24.5) (15.6) (20.3) (37.3) (11.9) 1.2 (0.9) (2.3)
Interest Expense 0 0 0 0 0 0 0 3.7 5.9 1.9 1.6 2.1 2.1 2.7
Interest Income 9.2 11.8 11.9 3.8 0.2 0.3 1.0 0 0 0 0 0 0 0
Profitability
EBITDA (0.7) (34.0) (84.9) (61.2) (17.8) (8.2) (17.4) (11.4) (14.6) (17.8) (11.3) 0.5 (0.2) (1.3)
EBIT (21.1) (53.8) (104.7) (77.2) (29.7) (17.7) (24.5) (15.6) (18.3) (24.8) (12.1) 0.0 (0.9) (2.3)
Income Before Tax (21.1) 52.9 (190.1) (76.2) (32.1) (19.8) (23.9) (48.2) (57.3) (41.4) (13.7) (0.7) (3.5) (5.1)
Income Tax Expense 0.3 0.3 0.1 0.4 (1.4) (1.0) (2.0) (1.4) (1.7) (1.6) 0 (1.5) 0 0
Net Income (21.4) 52.5 (190.3) (76.6) (30.7) (18.7) (22.0) (46.8) (55.5) (39.5) (13.7) 0.8 (3.5) (5.1)
Per Share Data
EPS (Basic) -0.40 1.00 -3.54 -1.44 -0.59 -0.40 -0.52 -1.31 -2.38 -2.39 -1.16 0.13 -0.48 -0.69
EPS (Diluted) -0.40 0.93 -3.54 -1.44 -0.59 -0.40 -0.52 -1.31 -2.38 -2.39 -1.16 0.10 -0.48 -0.69
Shares Outstanding 53.3 52.8 53.8 53.3 52.2 46.5 42.2 35.6 23.3 16.5 11.8 5.8 7.4 7.4
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Current Assets
Cash & Cash Equivalents 65.4 114.7 82.2 89.9 348.5 134.7 38.2 64.6 16.9 17.3
Short-Term Investments 111.8 146.0 153.2 203.2 0 90.0 0 0 0 0
Net Receivables 42.6 64.6 51.1 66.3 59.8 34.6 24.1 9.8 3.0 2.8
Inventory 26.7 19.5 19.5 19.2 17.2 10.0 6.0 4.9 5.5 5.5
Other Current Assets 10.6 7.1 7.8 9.2 0 0 0 1.8 1.4 1.2
Total Current Assets 257.1 351.8 313.7 387.8 433.4 273.1 71.9 81.1 26.8 26.7
Non-Current Assets
Property, Plant & Equipment 55.7 57.9 65.1 70.2 40.0 25.9 9.2 4.1 2.1 2.9
Goodwill 40.3 40.3 40.3 37.5 37.0 23.9 23.9 12.0 12.0 13.8
Intangible Assets 32.0 38.2 45.7 43.1 50.2 44.4 45.5 33.3 33.1 33.1
Long-Term Investments 0 0 0 0 0 0 0 0.2 9.6 0.1
Other Non-Current Assets 28.1 2.8 1.9 4.3 6.0 1.3 1.3 (3.5) (2.6) (2.9)
Total Non-Current Assets 156.1 139.2 153.1 155.1 133.3 95.4 79.8 49.6 56.8 50.1
Total Assets 413.2 491.1 466.8 543.0 566.6 368.5 151.7 130.7 83.6 76.7
Current Liabilities
Account Payables 10.0 7.7 12.9 9.9 13.3 9.7 5.5 4.7 3.4 3.1
Short-Term Debt 0 0 0 0 0 0 0 0 15.7 22.8
Deferred Revenue 0 4.8 4.7 5.3 4.2 24.0 3.7 0.0 0.0 0.0
Other Current Liabilities 79.9 41.1 26.2 21.3 32.8 21.2 15.4 9.2 18.8 5.8
Total Current Liabilities 89.8 89.4 78.1 76.0 77.3 69.2 34.8 19.5 42.9 40.8
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 18.3 1.1
Deferred Tax Liabilities 0.2 0.2 0.1 0 0.4 1.3 2.0 3.0 4.9 6.1
Other Non-Current Liabilities 0.4 0.8 99.0 2.7 5.6 4.2 13.6 11.6 22.6 8.2
Total Non-Current Liabilities 20.3 23.2 127.4 36.1 23.4 21.6 17.9 15.3 46.6 16.1
Total Liabilities 110.1 112.6 205.5 112.1 100.7 90.8 52.7 34.8 89.5 57.0
Stockholders' Equity
Common Stock 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0
Retained Earnings (735.4) (626.2) (678.3) (460.4) (383.2) (352.5) (333.8) (311.8) (268.0) (212.6)
Accumulated Other Comprehensive Income (5.5) (8.6) (7.0) (7.5) (4.7) (2.1) (5.2) (4.3) (2.3) (3.7)
Total Stockholders' Equity 303.1 378.4 261.3 430.9 465.9 277.7 99 95.9 (6.1) 19.5
Total Liabilities & Equity 413.2 491.1 466.8 543.0 566.6 368.5 151.7 130.7 83.6 76.7
Debt Metrics
Total Debt 19.7 28.4 34.2 39.0 21.4 18.1 5.4 0.2 34.1 23.9
Net Debt (45.8) (86.3) (48.0) (50.9) (327.1) (116.6) (32.8) (64.4) 17.2 6.7
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income (21.4) 52.5 (190.3) (76.6) (30.7) (18.7) (22.0) (46.8) (55.6) (39.8)
Depreciation & Amortization 20.4 19.8 19.8 16.0 11.9 9.5 7.1 4.2 3.8 2.9
Stock-Based Compensation 34.9 66.4 49.1 46.6 36.1 23.4 22.4 7.1 1.7 2.0
Change in Working Capital 3.8 (102.3) 106.0 (14.2) (41.0) 17.4 (10.4) (0.9) (1.1) 1.5
Other Non-Cash Items 4.3 1.8 (3.6) 3.0 4.4 1.8 0.1 33.9 39.0 18.2
Operating Cash Flow 42.0 38.0 (18.4) (25.2) (19.3) 33.4 (2.8) (4.0) (14.3) (16.5)
Investing Activities
Capital Expenditure (5.9) (6.5) (9.2) (24.3) (20.3) (10.4) (3.3) (7.2) (0.2) (0.5)
Acquisitions 0 0 (6.7) (0.6) (15.4) 0 (18.2) (0.7) (5.9) (20.6)
Purchases of Investments (145.9) (160.3) (201.2) (315.1) (5.5) (90.0) (1) 0 (0.1) 0
Sales/Maturities of Investments 154.7 166.9 256.0 111.6 88.9 0 0 0 0 0
Other Investing Activities 0 (7.1) 1.5 0 0 0 0 (5.2) (0.1) (20.6)
Investing Cash Flow 2.2 (0.5) 40.4 (228.5) 47.7 (100.4) (22.6) (7.9) (6.2) (21.1)
Financing Activities
Net Debt Issuance 0 0 0 0 (0.1) (0.2) (0.2) (14.5) 9.7 (3.9)
Stock Repurchased (87.8) (0.5) (27.5) (0.6) 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (13.6) (5.1) (2.1) (3.9) (3.1) 5.2 0.0 65.5 19.7 0.3
Financing Cash Flow (93.4) (5.6) (29.6) (4.5) 185.6 163.1 (0.1) 50.3 29.4 24.9
Cash Position
Net Change in Cash (49.3) 32.5 (7.7) (258.3) 213.8 96.5 (26.3) 38.3 (0.4) (12.6)
Cash at Beginning 115.3 82.8 90.4 348.7 134.9 38.5 64.8 26.5 17.3 29.9
Cash at End 66.0 115.3 82.8 90.4 348.7 134.9 38.5 64.8 16.9 17.3
Free Cash Flow 36.1 31.6 (27.6) (49.6) (39.6) 23.1 (6.1) (11.2) (14.5) (17.1)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Income Statement
Revenue 379.8 333.8 280.3 321.8 296.4 192.2 127.1 76.6 48.3 40.6 28.1 27.3 22.1 20.5
Gross Profit 254.4 224.2 178.3 209.6 199.0 129.1 81.6 43.6 27.0 19.5 17.9 18.8 13.0 12.5
Operating Income (21.0) 40.8 (203.4) (77.2) (29.7) (22.5) (24.5) (15.6) (20.3) (37.3) (11.9) 1.2 (0.9) (2.3)
Net Income (21.4) 52.5 (190.3) (76.6) (30.7) (18.7) (22.0) (46.8) (55.5) (39.5) (13.7) 0.8 (3.5) (5.1)
EPS (Diluted) -0.40 0.93 -3.54 -1.44 -0.59 -0.40 -0.52 -1.31 -2.38 -2.39 -1.16 0.10 -0.48 -0.69
Balance Sheet
Cash & Equivalents 65.4 114.7 82.2 89.9 348.5 134.7 38.2 64.6 16.9 17.3
Total Assets 413.2 491.1 466.8 543.0 566.6 368.5 151.7 130.7 83.6 76.7
Total Debt 19.7 28.4 34.2 39.0 21.4 18.1 5.4 0.2 34.1 23.9
Stockholders' Equity 303.1 378.4 261.3 430.9 465.9 277.7 99 95.9 (6.1) 19.5
Cash Flow
Operating Cash Flow 42.0 38.0 (18.4) (25.2) (19.3) 33.4 (2.8) (4.0) (14.3) (16.5)
Capital Expenditure (5.9) (6.5) (9.2) (24.3) (20.3) (10.4) (3.3) (7.2) (0.2) (0.5)
Free Cash Flow 36.1 31.6 (27.6) (49.6) (39.6) 23.1 (6.1) (11.2) (14.5) (17.1)